Infectious Disease and In-Hospital Pain Management

Volume 40, Number 1 (February, 2012)

Clinical Focus

• Antimicrobial Prophylaxis in Noncardiac Prosthetic Device Recipients
  David R. P. Guay, PharmD
• Outpatient Antibiotic Prescribing in a Low-Risk Veteran Population with Acute Respiratory Symptoms
  Jennifer L. Logan, MD, MPH; Jianji Yang, PhD; Graeme Forrest, MBBS
• Strategies for Prevention of Ventilator-Associated Pneumonia: Bundles, Devices, and Medications for Improved Patient Outcomes
  Fahad Alroumi, MD; Akmal Sarwar, MD; Philip E. Grgurich, PharmD; Yuxiu Lei, PhD; Jana Hudcova, MD; Donald E. Craven, MD
• Ventilator-Associated Pneumonia: A Review
  Madiha Ashraf, MD; Luis Ostrosky-Zeichner, MD
• Prevention and Management of Central Line–Associated Bloodstream Infections in Hospital Practice
  Stephen Y. Liang, MD; Hani Khair, MD; Michael J. Durkin, MD; Jonas Marschall, MD
• An Overview of the Diagnosis and Management of Clostridium difficile Infection
  Michael H. Hooper, MD, MSc; Ursula M. Kelly, MD; Paul E. Marik, MD, FCCM, FCCP
• Nosocomial Diarrhea: A Review of Pathophysiology, Etiology, and Treatment Strategies
  Billie Bartel, PharmD; Elizabeth Gau, PharmD
• Clostridium difficile Colitis: A Review
  Varsha Moudgal, MD; Jack D. Sobel, MD
• A Review of Opioids for In-Hospital Pain Management
  Eugene R. Viscusi, MD; Marco Pappagallo, MD
• Evaluating Therapeutic Benefit in Postsurgical Analgesia Requires Global Assessment: An Example From Liposome Bupivacaine in Hemorrhoidectomy
  William K. Schmidt, PhD; Gary Patou, MD; Girish P. Joshi, MBBS, MD, FFARCSI
• An Update in Options for the Treatment of Pain: A Review of New Opioid Formulations
  Sheila M. Seed, PharmD, MPH; Kaelen C. Dunican, PharmD; Ann M. Lynch, PharmD; Alicia R. Desilets, PharmD, CGP

Clinical Features

• Transition of Patients with COPD Across Different Care Settings: Challenges and Opportunities for Hospitalists
  Chan Chuang, MD, FCCP, FACP
• Occurrence and Predictors of Dexmedetomidine Infusion Intolerance and Failure
  Bethany R. Tellor, PharmD; Heather M. Arnold, PharmD; Scott T. Micek, PharmD; Marin H. Kollef, MD
• Routinely Assessed Biochemical Markers Tested on Admission as Predictors of Adverse Outcomes in Hospitalized Elderly Patients
  Siobhan H. M. Brown, BSc (Hons), MBChB, MRCP (UK); Katie Flint, BSc (Hons), MBChB; Allison Storey, MBChB; Ahmed H. Abdelhafiz, MBChB, MSc, FRCP, MD
• Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Spectrum and Therapeutic Strategies
  Yuebing Li, MD, PhD; Donna Jenny, RN; John Castaldo, MD
• Can Postoperative Cognitive Dysfunction Be Avoided?
  Christoph S. Burkhart, MD; Luzius A. Steiner, MD, PhD
• Contemporary Management of ST-Segment Elevation Myocardial Infarction
  Arun Karunakaran, MD, MRCP; Wael Sumaya, MD, MRCP; Julian P. Gunn, MD, MRCP; Allison C. Morton, PhD, MRCP; Robert F. Storey, DM, MRCP
• An Update on Coronary Artery Chronic Total Occlusions
  Kimberly Brayton, MD; Atif Mohammad, MD; Emmanouil S. Brilakis, MD, PhD; Subhash Banerjee, MD

Health Outcomes

• Evaluation of Costs Associated with Tolvaptan-Mediated Hospital Length of Stay Reduction Among US Patients with the Syndrome of Inappropriate Antidiuretic Hormone Secretion, Based on SALT-1 and SALT-2 Trials
  Joseph F. Dasta, MSc, FCCM, FCCP; Jun R. Chiong, MD, MPH; Rudell Christian, DrPH; Jay Lin, PhD, MBA
• Cost-Effectiveness Analysis of Varenicline Versus Existing Smoking Cessation Strategies in Central America and the Caribbean Using the BENESCO Model
  Manfred A. Lutz, MD; Pedro Lovato, MD; Genaro Cuesta, MD
• Cost Analysis of Varenicline Versus Bupropion, Nicotine Replacement Therapy, and Unaided Cessation in Nicaragua
  Manfred A. Lutz, MD; Pedro Lovato, MD; Genaro Cuesta, MD
• Coronary Artery Bypass Graft Surgery in Acute Coronary Syndrome: Incidence, Cost Impact, and Acute Clopidogrel Interruption
  Stephen S. Johnston, MA; Kelly Bell, PharmD, MSPhr; Joette Gdovin, PhD, MPA; Yonghua Jing, PhD; John Graham, PharmD